Breaking News, Financial News

Thermo Fisher Scientific

Acquisitions help with revenue growth

Thermo Fisher Scientific 4Q10

4Q Revenues: $2.8 billion (-2%)

4Q Earnings: $298 million (+9%)

FY Revenues: $10.8 billion (+7%)

FY Earnings: $1.0 billion (+22%)

Comments: Analytical Technologies revenues were $1.2 billion for 4Q10 (+4%) and $4.6 billion for FY (+11%). Laboratory Products and Services were -6% for 4Q10 ($1.7 billion) and +4% for FY ($6.7 billion). Acquisitions accounted for 3% of FY revenue growth and 2% of 4Q10 revenue growth. The company predicts revenue growth of 5-6% in 2011, not including sales generated by the Dionex acquisition, which has not yet closed.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters